Elevated cyclooxygenase-2 levels in Min mouse adenomas.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Gastroenterology

• Publication date

  1996-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0016-5085(96)70083-5PMID 8831610
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis.

  1996cited by this paper
• Chemoprevention of spontaneous intestinal adenomas in the Apc Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam.

  1996cited by this paper
• Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors.

  1996cited by this paper
• Prostaglandin endoperoxide synthase: why two isoforms?

  1996cited by this paper
• Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer.

  1995cited by this paper
• Eicosanoids and the gastrointestinal tract.

  1995cited by this paper
• Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene.

  1995cited by this paper
• Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2.

  1995cited by this paper
• Expression of cyclooxygenase-1 and -2 in human colorectal cancer.

  1995cited by this paper
• Inactivation of both APC alleles in human and mouse tumors.

  1994cited by this paper
• Loss of Apc+ in intestinal adenomas from Min mice.

  1994cited by this paper
• Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas.

  1994cited by this paper
• Cloning and characterization of a growth factor-inducible cyclooxygenase gene from rat intestinal epithelial cells.

  1994cited by this paper
• The NSAID sulindac reverses rectal adenomas in colectomized patients with familial adenomatous polyposis: clinical results of a dose-finding study on rectal sulindac administration

  1993cited by this paper
• Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis

  1993cited by this paper
• Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis.

  1993cited by this paper
• Corrections and Clarifications: Multiple Intestinal Neoplasia Caused By a Mutation in the Murine Homolog of the APC Gene

  1992cited by this paper
• A collection of mRNA species that are inducible in the RAW 264.7 mouse macrophage cell line by gamma interferon and other agents

  1992cited by this paper
• Identification of an immediate early gene, pghs-B, whose protein product has prostaglandin synthase/cyclooxygenase activity.

  1992cited by this paper
• Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients.

  1991cited by this paper
• Identification and characterization of the familial adenomatous polyposis coli gene

  1991cited by this paper
• Primary response genes induced by growth factors and tumor promoters.

  1991cited by this paper
• TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue.

  1991cited by this paper
• A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse.

  1990cited by this paper
• Identification of a phorbol ester-repressible v-src-inducible gene.

  1989cited by this paper
• Sulindac for polyposis of the colon.

  1989cited by this paper
• Genomic response to growth factors.

  1988cited by this paper
• Premalignancy of the mucosal polyp in the large intestine: I. Histologic gradation of the polyp on the basis of epithelial pseudostratification and glandular branching

  1975cited by this paper

• Novel insight on GRP/GRPR axis in diseases.

  2023cites this paper
• An Aspirin a Day: New Pharmacological Developments and Cancer Chemoprevention.

  2022cites this paper
• Cyclooxygenase 2-Regulated Genes an Alternative Avenue to the Development of New Therapeutic Drugs for Colorectal Cancer

  2020cites this paper
• Inflammation as a Therapeutic Target for Various Deadly Disorders: A Review.

  2019cites this paper
• 3,3'-Diindolylmethane inhibits patient-derived xenograft colon tumor growth by targeting COX1/2 and ERK1/2.

  2019cites this paper
• Influence of Pain and Analgesia on Cancer Research Studies.

  2019cites this paper
• Perspectives Aspirin Use and Potential Mechanisms for Colorectal Cancer Prevention

  2018cites this paper
• Insilico Investigation of CYP 1 A 1 Mediated Pathway Contribution in Liver Hepatocellular Carcinoma : A Drug Discovery Approach

  2018cites this paper
• Chronic Ethanol Consumption and Generation of Etheno-DNA Adducts in Cancer-Prone Tissues.

  2018cites this paper
• Bioactive lipid metabolism in platelet “first responder” and cancer biology

  2018cites this paper
• Natural Bioactive Food Components for Improving Enteral Tube Feeding Tolerance in Adult Patient Populations.

  2017cites this paper
• Leukotriene B4-receptor-1 mediated host response shapes gut microbiota and controls colon tumor progression

  2017cites this paper
• Mesenchymal Cells in Colon Cancer.

  2017cites this paper
• Chemopreventive action of non-steroidal anti-inflammatory drugs on the inflammatory pathways in colon cancer.

  2016cites this paper
• Mechanisms of nonsteroidal anti-inflammatory drugs in cancer prevention.

  2016cites this paper
• The Co-regulatory Role of 5-Lipoxygenase and Cyclooxygenase-2 in the Carcinogenesis and their Promotion by Cigarette Smoking in Colons.

  2016cites this paper
• Clinical Effects of NSAIDs and COXIBs in Colon Cancer Prevention

  2016cites this paper
• Changes of immunocytic phenotypes and functions from human colorectal adenomatous stage to cancerous stage: Update.

  2015cites this paper
• Prostaglandin E receptor 4 (EP4) promotes colonic tumorigenesis

  2015cites this paper
• Le système immunitaire dans la carcinogenèse colorectale : ami ou ennemi ?

  2015cites this paper
• Mouse models of intestinal cancer

  2015cites this paper
• Chemopreventive drugs : Mechanisms via inhibition of cancer stem cells in colorectal cancer

  2014cites this paper
• Chemopreventive drugs: mechanisms via inhibition of cancer stem cells in colorectal cancer.

  2014cites this paper
• A review on COX and their inhibitors: Present and future

  2014cites this paper
• Targeted Cox2 gene deletion in intestinal epithelial cells decreases tumorigenesis in female, but not male, ApcMin/+ mice

  2014cites this paper
• The role of reactive oxygen species (ROS) and cytochrome P-450 2E1 in the generation of carcinogenic etheno-DNA adducts

  2014cites this paper
• Nonsteroidal anti‐inflammatory drugs suppress cancer stem cells via inhibiting PTGS2 (cyclooxygenase 2) and NOTCH/HES1 and activating PPARG in colorectal cancer

  2014cites this paper
• Inflammatory colonic carcinogenesis: a review on pathogenesis and immunosurveillance mechanisms in ulcerative colitis.

  2014cites this paper
• Cancer Immunology at the Crossroads : Microbiology Microbes and In fl ammation in Colorectal Cancer

  2013influential citation
• Chemotherapeutic potential of Grape Seed Extract ( GSE ) against experimentally induced precancerous stage in mice colon

  2013cites this paper
• Pharmacologic Interventions with NSAIDs

  2013cites this paper
• Acetylsalicylic Acid and NS-398 Prevention of NNK-induced Lung Tumorigenesis in A/J Mice by

  2013cites this paper
• Endomicroscopic Imaging of COX-2 Activity in Murine Sporadic and Colitis-Associated Colorectal Cancer

  2013cites this paper
• 11β-Hydroxysteroid Dehydrogenase Type II is a Potential Target for Prevention of Colorectal Tumorigenesis.

  2013cites this paper
• Reduction of inflammatory bowel disease‐induced tumor development in IL‐10 knockout mice with soluble epoxide hydrolase gene deficiency

  2013cites this paper
• Avaliação das atividades mutagênica, pró-inflamatória e estrogênica de Machaerium hirtum e Crotalaria pallida

  2013cites this paper
• Cancer stem cell-suppressing effect of nonsteroidal anti-inflammatory drugs via cyclooxygenase-2-dependent and -independent pathways in colorectal cancer

  2012cites this paper
• Prostaglandins in Cancer Cell Adhesion, Migration, and Invasion

  2012cites this paper
• Hexahydrocurcumin enhances inhibitory effect of 5-fluorouracil on HT-29 human colon cancer cells.

  2012cites this paper
• Immune microenvironmental shift along human colorectal adenoma–carcinoma sequence: is it relevant to tumor development, biomarkers and biotherapeutic targets?

  2012cites this paper
• COX-derived prostanoid pathways in gastrointestinal cancer development and progression: novel targets for prevention and intervention.

  2012cites this paper
• Expression of COX-2 and E-cadherin in Tunisian patients with colorectal adenocarcinoma.

  2012cites this paper
• Peroxisome proliferator-activated receptor δ confers resistance to peroxisome proliferator-activated receptor γ-induced apoptosis in colorectal cancer cells

  2012cites this paper
• Colonic carcinogenesis in IBD: molecular events.

  2011cites this paper
• A Cyclooxygase-2 Inhibitor NS-398-Enhanced Apoptosis of Esophageal Carcinoma Cell EC9706 by Adjusting Expression of Survivin and Caspase-3

  2011cites this paper
• Cyclooxygenases and lipoxygenases in cancer

  2011cites this paper
• Preparation of polylactide-co-glycolide nanoparticles incorporating celecoxib and their antitumor activity against brain tumor cells

  2011cites this paper
• Mass Spectrometry in the Analysis of DNA, Protein, Peptide, and Lipid Biomarkers of Oxidative Stress

  2011cites this paper
• Nitric Oxide (NO) and Cyclooxygenase-2 (COX-2) Cross-Talk in Co-Cultures of Tumor Spheroids with Normal Cells

  2011cites this paper
• Cyclooxygenase- and lipoxygenase-mediated DNA damage

  2011cites this paper
• Selective cyclooxygenase-2 silencing mediated by engineered E. coli and RNA interference induces anti-tumour effects in human colon cancer cells

  2010cites this paper
• Selective visualization of cyclooxygenase-2 in inflammation and cancer by targeted fluorescent imaging agents.

  2010cites this paper
• Theoretical Investigation of NSAID Photodegradation Mechanisms

  2010cites this paper
• Cyclooxygenase-2 and Cancer Treatment: Understanding the Risk Should Be Worth the Reward

  2010cites this paper
• Germinated brown rice (GBR) reduces the incidence of aberrant crypt foci with the involvement of β-catenin and COX-2 in azoxymethane-induced colon cancer in rats

  2010cites this paper
• Cyclooxygenase-2 expression and recurrence of colorectal adenomas: effect of aspirin chemoprevention

  2010cites this paper
• Detection and Localization of Anti and Pro-apoptotic mRNA Genes in Human Colorectal Cancer Using in situ RT-PCR

  2010cites this paper
• Prostanoids and colorectal cancer

  2010cites this paper
• COX‐2 expression is unexpectedly high in viable colorectal mucosal cells: is there life for chemoprophylaxis after VICTOR?

  2009cites this paper
• Efectos protectores de los Ácidos grasos Omega-3 en el hígado y el tejido adiposo

  2009cites this paper
• A reciprocal relationship exists between non-steroidal anti-inflammatory drug-activated gene-1 (NAG-1) and cyclooxygenase-2.

  2009cites this paper
• Cyclooxygenase as a target for chemoprevention in colorectal cancer: lost cause or a concept coming of age?

  2009cites this paper
• Role of Cyclooxygenase-2 in Tumor Progression and Survival of Head and Neck Squamous Cell Carcinoma

  2009cites this paper
• The Ron receptor tyrosine kinase in tissue morphogenesis.

  2009cites this paper
• The effect of omega-3 FAs on tumour angiogenesis and their therapeutic potential.

  2009cites this paper
• Intestinal adenoma formation and MYC activation are regulated by cooperation between MYB and Wnt signaling

  2009cites this paper
• The Ron receptor tyrosine kinase is not required for adenoma formation in ApcMin/+ mice

  2009cites this paper
• The Role of Prostaglandin E2/EP4 Prostanoid Receptor Signaling in Colorectal Carcinogenesis

  2009cites this paper
• Inhibition of Cyclooxygenase‐2 Suppresses Lymph Node Metastasis via VEGF‐C

  2009cites this paper
• Immune Modulation and Cancer Resistance

  2008cites this paper
• Multi-Target Approaches in Colon Cancer Chemoprevention Based on Systems Biology of Tumor Cell-Signaling

  2008cites this paper
• Cyclooxygenase activity and tumor progression

  2008cites this paper
• Synergistic Regulation of COX-2 Expression by Bombesin and Transforming Growth Factor-β

  2008cites this paper
• Mechanism of Growth Inhibitory Effects of Cyclooxygenase-2 Inhibitor–NS398 on Cancer Cells

  2008cites this paper
• Correlation of pit pattern by magnifying colonoscopy with histologic features and COX-2 expression in colonic polyps

  2008cites this paper
• Angiotensin II bi-directionally regulates cyclooxygenase-2 expression in intestinal epithelial cells

  2008cites this paper
• Cyclooxygenase activity and tumor progression

  2008cites this paper
• Relationships between intestinal polyp formation and fatty acid levels in plasma, erythrocytes, and intestinal polyps in Min mice

  2008cites this paper
• Curcumin downregulates the constitutive activity of NF-κB and induces apoptosis in novel mouse melanoma cells

  2007cites this paper
• hMLH1, hMSH2 and cyclooxygenase-2 (cox-2) in sporadic colorectal polyps.

  2007cites this paper
• Overproduction of PGE2 in peripheral blood monocytes of gastrointestinal cancer patients with mucins in their bloodstream.

  2007cites this paper
• Papel de los mediadores lipídicos derivados del ácido araquidónico en la inflamación y la fibrogénesis hepática

  2007cites this paper
• [Possibilities of prevention of colonic neoplasms].

  2007cites this paper
• The role of NSAIDs in colon cancer prevention.

  2007cites this paper
• Bombesin induces cyclooxygenase-2 expression through the activation of the nuclear factor of activated T cells and enhances cell migration in Caco-2 colon carcinoma cells

  2007cites this paper
• Ras‐mediated intestinal epithelial cell transformation requires cyclooxygenase‐2‐induced prostaglandin E2 signaling

  2007cites this paper
• The effect of cyclooxygenase‐2 overexpression on skin carcinogenesis is context dependent

  2007cites this paper
• Ciclooxigenasa 2 y cáncer colorrectal : implicaciones terapéuticas

  2007cites this paper
• 6. Possibilities of Prevention of Colorectal Cancer

  2007cites this paper
• [Cyclooxygenase 2 and colorectal cancer: therapeutic implications].

  2007cites this paper
• Deletion of the AU-rich RNA binding protein Apobec-1 reduces intestinal tumor burden in Apc(min) mice.

  2007cites this paper
• New approaches to the modulation of the cyclooxygenase-2 and 5-lipoxygenase pathways.

  2007cites this paper
• Effect of azoxymethane and curcumin on transcriptional levels of cyclooxygenase-1 and -2 during initiation of colon carcinogenesis

  2007cites this paper
• Endogenous Lipid Hydroperoxide-mediated DNA-adduct Formation in Min Mice*

  2006cites this paper
• In vitro-Evaluation kombinierter immunologischer und pharmakologischer Therapiestrategien zur Behandlung des Pankreaskarzinoms

  2006cites this paper
• Effect of dietary estrogens on cellular markers of colon cancer in mice

  2006cites this paper
• Cyclooxygenase-2 knockdown by RNA interference in colon cancer.

  2006cites this paper
• Cyclo-Oxygenase-2 Inhibitors in Colorectal Cancer Prevention

  2006cites this paper
• Patients with Familial Adenomatous Polyposis Size-dependent Increase in Prostanoid Levels in Adenomas of Updated Version

  2006cites this paper
• Expression of cyclooxygenase-2 in colorectal adenocarcinoma is associated with p53 accumulation and hdm2 overexpression.

  2006cites this paper